Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study
暂无分享,去创建一个
D. Lye | C. Chiew | V. Lee | Benjamin K. Ong | C. Y. Tan | Deanette Pang | K. B. Tan
[1] Peng Wang,et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution , 2022, bioRxiv.
[2] Gheyath K Nasrallah,et al. Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants , 2022, The New England journal of medicine.
[3] H. Ullum,et al. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark , 2022, The Lancet Infectious Diseases.
[4] R. Ribeiro,et al. Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants , 2022, The New England journal of medicine.
[5] D. Lye,et al. Vaccine effectiveness against Delta, Omicron BA.1, and BA.2 in a highly vaccinated Asian setting: a test-negative design study , 2022, Clinical Microbiology and Infection.
[6] W. Schaffner,et al. Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[7] E. Lau,et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study , 2022, The Lancet Infectious Diseases.
[8] Gheyath K Nasrallah,et al. Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections , 2022, The New England journal of medicine.
[9] J. Skarbinski,et al. Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study , 2022, The Lancet Regional Health - Americas.
[10] Michael I. Mandel,et al. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel , 2021, The New England journal of medicine.
[11] Purhadi,et al. The Comparison Of Generalized Poisson Regression And Negative Binomial Reression Methods In Overcoming Overdispersion , 2013 .